Restructuring at Celera Brings Changes to the Top

genomeweb
360dx

Restructuring at Celera Brings Changes to the Top

Jun 13, 2002

NEW YORK, June 13 - Celera's plans to create a drug-discovery staff must still be hammered out, but the company restructuring has already retooled the jobs of its human-genome leaders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Illumina Revenues Increase 20 Percent in Q3
Warfarin Bleeding Risk SNPs Identified in African Americans
Amazon Web Services Partners With NIH Cloud Initiative for Biomedical Research
Proteona Licenses Sequencing-Based Protein Analysis Technology
MDxHealth's Product Sales Jump but Lower Royalty Revenue Hits Top-Line Results
Synthego Raises $110M in Series C Funding Round

The Scan

Laureates Warn Against Hard Brexit

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

For All

Vox reports on inequities in genetic research and efforts to address them.

Lawrence Krauss to Retire Following Sexual Misconduct Allegations

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

This Week in PNAS

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.

Main menu